Trial intelligence / Profile preview

Fozivudine tidoxil in HIV-1 Infection

NCT00002385Phase 2Completed

Sponsor
Anderson Clinical Research
Modality
Small Molecules
01

Overview

A Phase 2 trial of fozivudine tidoxil in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Anderson Clinical Research. Status: completed.

02

Drugs

fozivudine tidoxil
03

Conditions

human immunodeficiency virus type 1 infection (HIV-1)

Beyond the preview

Go deeper on NCT00002385.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002385.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call